BELLEVUE, Wash., July 11, 2012 /PRNewswire/ -- Summit Associates International today announced that it was awarded US Patent 8,183,204, on methods and compositions for increasing skin remodeling. The patent describes the use of metal peptides for helping to diminish or remove various skin imperfections, including wound and surgical scars, acne scars, keloids, skin tags, benign skin moles, stretch marks, facial keratosis, sunspots, or a vitiligo.
The inventor, Dr. Loren Pickart, previously discovered the human skin-remodeling, copper-binding peptide GHK, and then developed clinically-proven methods for its use in cosmetic skin improvement, hair growth, and hair transplantation. Recent published work from numerous universities found that GHK controls or heavily influences 17% of the human genome, and also possesses a multiplicity of "wellness" properties including regeneration of tissues, activation of quiescent stem cells, suppression of numerous cancer metastasis genes, plus anti-inflammatory and anti-infection actions.
"The real cause of aging and most diseases is the silencing of regenerative and protective genes," said Dr. Pickart, "At age 25, our genes produce the healthiest mix of proteins, then gene silencing reduces the effect of our regenerative genes and increases the influence inflammatory and cancer-promoting genes. Summit Associates is also focused on developing and patenting methods of re-programming the human gene pattern to inhibit cancer growth and the effects of human senescence."
Summit Associates is Dr. Pickart's research group and located in Bellevue, WA. More information can be found at www.summit-associates-intl.com
Dr. Loren Pickart
|SOURCE Summit Associates International|
Copyright©2012 PR Newswire.
All rights reserved